Myriad Genetics Inc. Equity-NMS: MYGN

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$18.85

52W high :

$28.45

1Y :

-39.87%

5Y :

-47.69%

EPS(TTM): :

-0.9708

Shares O/S :

81.03 M

Market cap :

1.55 B

What is the share price of Myriad Genetics Inc. today?

Myriad Genetics Inc. (MYGN) share price as of October 11, 2022, is $18.93. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Myriad Genetics Inc.?

Yes, Indian Investors can invest in the Myriad Genetics Inc. (MYGN) Share by opening an international trading account with Angel One.

How can I purchase Myriad Genetics Inc. shares in India?

Purchasing Myriad Genetics Inc. (MYGN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Myriad Genetics Inc. (MYGN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Myriad Genetics Inc.?

Yes, you can purchase fractional shares of Myriad Genetics Inc. (MYGN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Myriad Genetics Inc.?

The market capitalization of Myriad Genetics Inc. on November 29, 2022, is $1.53 B.

In which sector Myriad Genetics Inc. belongs?

Myriad Genetics Inc. operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Myriad Genetics Inc. stocks?

In order to invest in Myriad Genetics Inc. (MYGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company primarily provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing the disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression, and includes corporate services, such as finance, human resources, legal and information technology. The Company discovers and commercializes genetic tests. The Company's products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight and Prequel, GeneSight, Vectra. The Company offers SneakPeek Early Gender DNA Test, which reveals a baby’s gender at six weeks into pregnancy. Its wholly owned subsidiaries include Myriad Genetic Laboratories, Inc., Assurex Health, Inc. and Myriad Women’s Health, Inc.